Announce Date | 04/30/2025 |
EPS Normalized Actual | $0.767 (Beat by $0.027) |
EPS GAAP Actual | $0.767 (Beat by $0.027) |
Revenue Actual | $3.795B |
Revenue Surprise | Beat by $3795M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 7.5766 | 10.62 | 6.99996 | 8.24187 | 1 |
Dec 2028 | 7.7647 | 10.36 | 7.20051 | 8.02207 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.98 | 0.98 | 3.795B | 7.25% | 3795M |
FQ4 2024 (Dec 2024) | 1.29 | 1.29 | 3.874B | 100% | 3874M |
FQ3 2024 (Sep 2024) | 0.9 | 0.9 | 3.549B | 5.92% | 3549M |
FQ2 2024 (Jun 2024) | 0.97 | 0.97 | 3.603B | 11.91% | 3603M |
FQ1 2024 (Mar 2024) | 0.83 | 0.83 | 3.52B | 35.63% | 3520M |
FQ4 2023 (Dec 2023) | 0 | 0 | 0B | -INF% | 0M |
FQ3 2023 (Sep 2023) | 0.84 | 0.84 | 3.339B | 30.76% | 3339M |
FQ2 2023 (Jun 2023) | -7.12 | -7.12 | 3.174B | 30.62% | 3174M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2029 (Sep 2029) | 2.29191 | -- | 2.22779 | 2.39586 | 7 |
FQ2 2029 (Jun 2029) | 2.20567 | -- | 2.14397 | 2.30571 | 7 |
FQ1 2029 (Mar 2029) | 2.02101 | -- | 1.84195 | 2.11374 | 9 |
FQ4 2028 (Oct 2028) | 1.97387 | -- | 1.83817 | 2.06699 | 12 |
FQ3 2028 (Jul 2028) | 1.74228 | -- | 1.6225 | 1.82448 | 7 |
FQ2 2028 (Jun 2028) | 1.77116 | -- | 1.63329 | 1.85848 | 7 |
FQ1 2028 (Mar 2028) | 1.75283 | -- | 1.61639 | 1.83924 | 7 |
FQ4 2027 (Oct 2027) | 1.74982 | -- | 1.62952 | 1.83237 | 7 |
FQ3 2027 (Jul 2027) | 1.5442 | -- | 1.43804 | 1.61705 | 6 |
FQ2 2027 (Jun 2027) | 1.59684 | -- | 1.47254 | 1.67556 | 6 |
FQ1 2027 (Mar 2027) | 1.41114 | -- | 1.31413 | 1.47771 | 9 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2029 (Sep 2029) | 5.38B | -- | 5.27B | 5.57B | 10 |
FQ2 2029 (Jun 2029) | 5.31B | -- | 5.19B | 5.49B | 9 |
FQ1 2029 (Mar 2029) | 5.17B | -- | 4.82B | 5.35B | 7 |
FQ4 2028 (Oct 2028) | 6.31B | -- | 5.97B | 6.53B | 6 |
FQ3 2028 (Jul 2028) | 6.1B | -- | 5.78B | 6.33B | 5 |
FQ2 2028 (Jun 2028) | 20.77B | -- | 19.52B | 21.56B | 4 |
FQ1 2028 (Mar 2028) | 19.82B | -- | 18.64B | 20.58B | 4 |
FQ4 2027 (Oct 2027) | 5.54B | -- | 5.25B | 5.74B | 6 |
FQ3 2027 (Jul 2027) | 5.36B | -- | 5.08B | 5.56B | 6 |
FQ2 2027 (Jun 2027) | 16.99B | -- | 15.97B | 17.64B | 5 |
FQ1 2027 (Mar 2027) | 5.19B | -- | 4.92B | 5.38B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
1
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.98 | 0.98 | 100% | |
FQ4 2024 (Dec 2024) | 1.29 | 1.29 | 100% | |
FQ3 2024 (Sep 2024) | 0.9 | 0.9 | 100% | |
FQ2 2024 (Jun 2024) | 0.97 | 0.97 | 100% | |
FQ1 2024 (Mar 2024) | 0.83 | 0.83 | 100% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | 0.84 | 0.84 | 100% | |
FQ2 2023 (Jun 2023) | -7.12 | -7.12 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $3.8B | $3795M | 100% |
FQ4 2024 (Dec 2024) | $0B | $3.87B | $3874M | 100% |
FQ3 2024 (Sep 2024) | $0B | $3.55B | $3549M | 100% |
FQ2 2024 (Jun 2024) | $0B | $3.6B | $3603M | 100% |
FQ1 2024 (Mar 2024) | $0B | $3.52B | $3520M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0B | $0M | NAN% |
FQ3 2023 (Sep 2023) | $0B | $3.34B | $3339M | 100% |
FQ2 2023 (Jun 2023) | $0B | $3.17B | $3174M | 100% |